Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life

S.L. Kanis*, S. Modderman, J.C. Escher, N. Erler, R. Beukers, N. de Boer, A. Bodelier, A.C.T.M. Depla, G. Dijkstra, A.B.R.M. van Dijk, L. Gilissen, F. Hoentjen, J.M. Jansen, J. Kuyvenhoven, N. Mahmmod, R.C. Mallant-Hent, A.E. Van der Meulen-de Jong, A. Noruzi, B. Oldenburg, L.E. OostenbrugP.C.J. Ter Borg, M. Pierik, M. Romberg-Camps, W. Thijs, R. West, A. de Lima, C.J. van der Woude, Crohns Initiative, Initiative on Crohns and Colitis (ICC)

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1266-1274
Number of pages9
JournalGut
Volume70
Issue number7
DOIs
Publication statusPublished - 1 Jul 2021

Keywords

  • TNF-ALPHA DRUGS
  • INTRAUTERINE EXPOSURE
  • PREGNANCY
  • WOMEN
  • IMMUNOGLOBULINS
  • AZATHIOPRINE
  • THIOPURINES
  • INFLIXIMAB
  • TRANSPORT
  • THERAPIES

Cite this